SPB11N60S5 Cool MOS™ Power Transistor: Feature
SPB11N60S5 Cool MOS™ Power Transistor: Feature
Maximum Ratings
Parameter Symbol Value Unit
Continuous drain current ID A
TC = 25 °C 11
TC = 100 °C 7
Pulsed drain current, tp limited by Tjmax I D puls 22
Avalanche energy, single pulse EAS 340 mJ
I D = 5.5 A, VDD = 50 V
Avalanche energy, repetitive tAR limited by Tjmax1) EAR 0.6
I D = 11 A, VDD = 50 V
Avalanche current, repetitive tAR limited by Tjmax I AR 11 A
Gate source voltage VGS ±20 V
Gate source voltage AC (f >1Hz) VGS ±30
Power dissipation, T C = 25°C Ptot 125 W
Operating and storage temperature T j , T stg -55... +150 °C
Maximum Ratings
Parameter Symbol Value Unit
Drain Source voltage slope dv/dt 20 V/ns
V DS = 480 V, ID = 11 A, Tj = 125 °C
Thermal Characteristics
Parameter Symbol Values Unit
min. typ. max.
Thermal resistance, junction - case RthJC - - 1 K/W
Thermal resistance, junction - ambient, leaded RthJA - - 62
SMD version, device on PCB: RthJA
@ min. footprint - - 62
@ 6 cm2 cooling area 2) - 35 -
Soldering temperature, reflow soldering, MSL1 Tsold - - 260 °C
1.6 mm (0.063 in.) from case for 10s
1Repetitve avalanche causes additional power losses that can be calculated as P =EAR*f.
AV
2Device on 40mm*40mm*1.5mm epoxy PCB FR4 with 6cm² (one layer, 70 µm thick) copper area for drain
connection. PCB is vertical without blown air.
3C is a fixed capacitance that gives the same stored energy as Coss while VDS is rising from 0 to 80% V
o(er) DSS.
4C o(tr) is a fixed capacitance that gives the same charging time as Coss while VDS is rising from 0 to 80% VDSS.
T am b
110
10 1
100
Ptot
90
ID
80
70 10 0
60
50 tp = 0.001 ms
40 tp = 0.01 ms
10 -1 tp = 0.1 ms
30 tp = 1 ms
20
DC
10
0 10 -2 0 1 2 3
0 20 40 60 80 100 120 °C 160 10 10 10 V 10
TC VDS
25
ZthJC
ID
10 -1 9V
20
D = 0.5
15
10 -2 D = 0.2
D = 0.1 8V
D = 0.05
D = 0.02 10
10 -3 D = 0.01
single pulse 7V
5
6V
10 -4 -7 -6 -5 -4 -3 -1 0
10 10 10 10 10 s 10 0 5 10 15 VDS 25
tp V
A 20V
12V
10V 9V
14 mΩ
RDS(on)
8V
12
ID
10
20V
1
12V
8 10V
7V 9V
6 8V
7V
0.5 6V
4
6V
0 0
0 5 10 15 V 25 0 2 4 6 8 10 12 14 A 18
VDS ID
1.6 24
RDS(on)
1.4
ID
20 25 °C
1.2 150 °C
16
1
0.8 12
0.6
98% 8
0.4 typ
4
0.2
0 0
-60 -20 20 60 100 °C 180 0 4 8 12 V 20
Tj VGS
V
A
0.2 VDS max
10 1
VGS
10
IF
8
6
10 0
Tj = 25 °C typ
4
Tj = 150 °C typ
Tj = 25 °C (98%)
2 Tj = 150 °C (98%)
0 10 -1
0 10 20 30 40 50 nC 65 0 0.4 0.8 1.2 1.6 2 2.4 V 3
QGate VSD
8 250
EAS
IAR
7
200
6
5 Tj (START) =25°C
150
4
3 Tj (START) =125°C
100
2
50
1
0 -3 -2 -1 0 1 2 4 0
10 10 10 10 10 10 µs 10 20 40 60 80 100 120 °C 160
tAR Tj
V
W
680
V(BR)DSS
PAR
660 200
640
150
620
600 100
580
50
560
540 0 4 5 6
-60 -20 20 60 100 °C 180 10 10 Hz 10
Tj f
5
C
4.5
4
10 2
Coss
3.5
3
2.5
1 2
10 Crss
1.5
1
0.5
10 0 0
0 100 200 300 400 V 600 0 100 200 300 400 V 600
VDS VDS
Published by
Infineon Technologies AG,
Bereichs Kommunikation
St.-Martin-Strasse 53,
D-81541 München
© Infineon Technologies AG 1999
All Rights Reserved.
Attention please!
The information herein is given to describe certain components and shall not be considered as warranted
characteristics.
We hereby disclaim any and all warranties, including but not limited to warranties of non-infringement,
regarding circuits, descriptions and charts stated herein.
Information
For further information on technology, delivery terms and conditions and prices please contact your nearest
Infineon Technologies Office in Germany or our Infineon Technologies Reprensatives worldwide (see address list).
Warnings
Due to technical requirements components may contain dangerous substances.
For information on the types in question please contact your nearest Infineon Technologies Office.
Infineon Technologies Components may only be used in life-support devices or systems with the express
written approval of Infineon Technologies, if a failure of such components can reasonably be expected to
cause the failure of that life-support device or system, or to affect the safety or effectiveness of that device
or system Life support devices or systems are intended to be implanted in the human body, or to support
and/or maintain and sustain and/or protect human life. If they fail, it is reasonable to assume that the health
of the user or other persons may be endangered.